The SWIBREG application is used in Sweden and Denmark, in Sweden it is also the national quality register for IBD care.
Inflammatory Bowel Disease (IBD) patients can be symptom free for long stretches of time but can then relapse into their disease. It is challenging for healthcare to keep track of the patients’ health since there are no perfect lab tests or similar that can be used to predict a relapse. IBD physicians have therefore developed questionnaires that are used to follow and predict the disease. These questionnaires are an essential part of the RealQ application SWIBREG.